Mental Attention-neuromuscular Training for Children With Developmental Coordination Disorder
NCT ID: NCT02397161
Last Updated: 2015-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
172 participants
INTERVENTIONAL
2016-07-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To compare the effectiveness of AT-NMT, NMT alone, AT alone, and no intervention for improving reactive balance performance among children with DCD.
Design: A single-blinded, randomized controlled clinical trial. Sample: 172 children with DCD. Interventions: AT-NMT, NMT, AT, or no intervention for 12 weeks. Major outcomes: Outcomes will be evaluated at baseline, post-intervention, and 3-month follow-up. A motor control test (MCT) will give a composite latency score, prefrontal cortex EEG recordings during MCT will measure the mental attention level, and surface electromyography recordings during MCT will indicate the lower limb muscle onset latency.
Anticipated results and clinical significance: Children with DCD who receive AT-NMT will have the best reactive balance performance outcomes. If the results are positive, this novel training regime can be readily adopted in clinical practice. AT-NMT will improve overall well-being in these children and have positive socio-economic implications such as shorter rehabilitation periods and reduced healthcare costs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AT-NMT
AT-NMT group - will receive a 12-week EEG biofeedback mental attention-neuromuscular training
EEG biofeedback mental attention-neuromuscular training
Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises
NMT alone
NMT group - will receive a 12-week neuromuscular training
Neuromuscular training
Neuromuscular training using physio-therapeutic exercises
AT alone
AT group - will receive a 12-week EEG biofeedback mental attention training
EEG biofeedback mental attention training
Mental attention training using EEG biofeedback
Control
Control group - no intervention for 12 weeks
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EEG biofeedback mental attention-neuromuscular training
Mental attention training using EEG biofeedback and neuromuscular training using physio-therapeutic exercises
Neuromuscular training
Neuromuscular training using physio-therapeutic exercises
EEG biofeedback mental attention training
Mental attention training using EEG biofeedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. a formal diagnosis of DCD based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) at a child assessment center;
3. a Bruininks-Oseretsky Test of Motor Proficiency giving a gross motor composite score of ≤42;
4. a Child Behavior Checklist attention problem subscale T score of ≥54.5, indicating an attention deficit;
5. attending a local mainstream school;
6. an intelligence level within the normal range; and
7. no experience in using the Brain Computer Interface system or similar apparatus.
Exclusion Criteria
2. any cognitive, psychiatric (comorbid ADHD will not be excluded), congenital, musculoskeletal or cardiopulmonary disorder that can affect motor performance;
3. receiving active therapies or treatments including complementary and alternative medicine;
4. demonstrating excessive disruptive behavior; or
5. those unable to follow instructions adequately.
6 Years
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shirley S.M. Fong
Assistant Professor, DRPC chairperson
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shirley SM Fong, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Hong Kong
Pokfulam, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shirley SM Fong, PT, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17120515
Identifier Type: -
Identifier Source: org_study_id